Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Probiomed has been acquired by Sanfer
The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.
Learn more
Jan De Backer
CEO, Fluidda NV
Read more
Scale, specialization and capital shape Q2 transactions
QUARTERLY M&A ACTIVITY: In Q2 2026, Oaklins’ clients completed 69 transactions across sectors and regions, reflecting active dealmaking in healthcare, TMT and specialist services, with scale, specialization and capital as recurring themes.
Learn more